Plain-English translation of NCT07568613 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two newer imaging methods—called MRI-RSI and PSMA PET/CT—can better detect and outline prostate cancer tumors compared to the current standard imaging approach. The study wants to see if these newer scans are more accurate and reliable, which could help doctors plan better treatment for men with newly diagnosed prostate cancer.
The current standard imaging sometimes misses cancer or leads doctors to estimate tumor size differently. By comparing these two newer imaging methods, researchers hope to find a better way to detect prostate cancer tumors and plan more personalized treatment.
You likely qualify if…
You likely don't qualify if…
You will have two advanced imaging scans: an MRI-RSI scan and a PSMA PET/CT scan. Both are non-invasive and painless—you simply lie still in the scanner while images are taken. The researchers will compare these new scans with your standard MRI to see which method best detects and outlines your cancer, helping guide future treatment decisions. The study involves no new medications or invasive procedures beyond the imaging you would likely already have.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Cyprus